4C Medical Technologies
4C Medical Technologies, Inc. is a privately held, clinical-stage medical device company headquartered at 6655 Wedgwood Road North, Suite 160, Maple Grove, Minnesota, developing minimally invasive therapies for structural heart disease. Its lead product is the AltaValve System, a supra-annular transcatheter mitral valve replacement (TMVR) device delivered by transseptal or transapical catheter and designed to expand the treatable severe mitral regurgitation patient population, streamline the procedure and preserve the native mitral valve; the device is fully recapturable until released from the delivery catheter. AltaValve holds FDA Breakthrough Device designation and is enrolling the ATLAS global pivotal trial (NCT06465745) in the United States and Europe. The company closed a $175M Series D financing led by Boston Scientific in March 2025. It is a physical medical device manufacturer and publishes no developer program, public API, SDK or machine-readable API contract of any kind.
4C Medical Technologies is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health, Cardiology, and Structural Heart.
4C Medical Technologies’ developer surface includes engineering blog and 2 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.